DANIEL R MARSHAK
CIK 1192624 · SVP & CSO · last filed 2022-11-21
DANIEL R MARSHAK is a SVP & CSO who has filed 27 SEC Form 4 insider transactions across 2 companies since 2009. The most recent filing, for NVIV, was dated Nov 21, 2022. Across all open-market trades the lifetime net is −$2.5M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
27
-$2.52M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Director | — | $0.32 | — | $0 | 5 | 2022-11-21 |
| REVVITY, INC. (PKI) Delisted | SVP & CSO | 79,293 | $115.24 | $9.14M | -$2.52M | 20 | 2014-09-29 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-11-21 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-22 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-23 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-01-23 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-12-11 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-12-11 | — | Grant (A) | — | $0 | |
| 2014-09-30 | — | Grant (A) | — | $0 | |
| 2014-09-29 | REVVITY, INC. (PKI) Delisted | Disp (D) | −19,667 | $0 | EDGAR |
| 2014-08-07 | REVVITY, INC. (PKI) Delisted | Exer (M) | +41,965 | $796.4K | EDGAR |
| 2014-07-09 | REVVITY, INC. (PKI) Delisted | Mixed | — | -$2.7K | EDGAR |